depression treatment
The latest news about depression treatment: headlines, AI summaries and the full story from every source.
- Eli Lilly Acquires AtaiBeckley in $2.8 Billion Deal; Cathie Wood Shifts Focus to Compass Pathways
- Eli Lilly Acquires AtaiBeckley for $2.8 Billion to Expand Neuroscience Portfolio
- Eli Lilly Acquires AtaiBeckley for Up to $3.8 Billion
- NRx Pharmaceuticals Announces FDA Approval for Expanded Access Protocol and Addresses Acquisition Dispute
- Neumora Therapeutics Faces Key Catalyst With Upcoming Navacaprant Depression Data
- Blue Cross Blue Shield of South Carolina Approves Coverage for TMS Treatments for OCD and Depression